Matthew Weston

Stock Analyst at UBS

(0)
# 4018
Out of 5,328 analysts
3
Total ratings
0.00%
Success rate
-3.57%
Average return
Main Sectors:
2 Stocks
Name Action PT Current % Upside Ratings Updated
NVS Novartis
Downgrades: Neutral
n/a
n/a n/a 1 Feb 13, 2025
AZN AstraZeneca
Upgrades: Buy
n/a
n/a n/a 2 Feb 13, 2025